2Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population based European Prospective Investigation into Cancer and Nutrition(EPIC)-Potsdam study[J]. Diabetes,2003,52(3) :812-817.
3Colwell GA. Inflammation and diabetic vascular complications[J]. Diabetes Care, 1999,22(12) : 1927-1928.
2Koenig W,Sund M,Frohlich M,et al.C-Reactive protein,a sensitive marker of inflammation,predicts future risk of coronary heart disease in initially healthy middle-aged men:results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Diseas
3Spranger J,Kroke A,Mohlig M,et al.Inflammatory cytokines and the risk to develop type 2 diabetes:results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.Diabetes,2003,52(3):812-817.
4Yudkin JS,Panahloo A,Stehouwer C,et al.The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.Diabetologia,2000,43(9):1099-1106.
6Ford ES.Body mass index,diabetes,and C-reactive protein among U.S.adults.Diabetes Care,1999,22(12):1971-1977.
7Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus.JAMA,2001,286(3):327-334.
8Taniguchi A,Nagasaka S,Fukushima M,et al.C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients.Metabolism,2002,51(12):1578-1581.
9Colwell GA.Inflammation and diabetic vascular complications.Diabetes Care,1999,22(12):1927-1928.
10Woodman RJ,Watts GF,Puddey IB,et al.Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension.Atherosclerosis,2002,163(1):175-181.
